Metformin Hydrochloride Metformin

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Metformin, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus. It helps lower elevated blood sugar levels by targeting multiple pathways involved in glucose metabolism.

GNH USA supplies Metformin Hydrochloride Metformin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable sourcing for healthcare providers.

Metformin Hydrochloride is indicated for the management of disorders affecting glucose metabolism, primarily type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often transient. - Abdominal discomfort: cramping or pain. - Metallic taste: altered taste sensation. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatotoxicity: liver enzyme elevations. - Hypoglycaemia: when combined with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas. - Anemia: due to reduced red blood cell production.

Metformin Hydrochloride requires careful monitoring and patient education before initiation.

- Renal function assessment: evaluate creatinine clearance to avoid accumulation. - Hepatic function review: check liver enzymes for underlying disease. - Lactic acidosis risk: avoid in patients with hypoxia, heart failure, or severe infection. - Concomitant medication review: assess for drugs that may impair renal clearance. - Elderly monitoring: adjust dose and monitor for dehydration. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: can affect renal function. - Diuretics: may lead to dehydration and reduced clearance. - Sulfonylureas: increase risk of hypoglycaemia. - Warfarin: may require INR monitoring.